Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2021 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2021 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis

  • Authors:
    • Bihao Peng
    • Xiaojian Qiu
    • Zhiwu Dong
    • Jie Zhang
    • Yinghua Pei
    • Ting Wang
  • View Affiliations / Copyright

    Affiliations: The Second Clinical Medical College, Nanchang University, Nanchang, Jiangxi 330000, P.R. China, Department of Pulmonary Diseases, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Laboratory Medicine, Shanghai Sixth People's Hospital Jinshan Branch, Shanghai 201599, P.R. China
    Copyright: © Peng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 63
    |
    Published online on: November 19, 2020
       https://doi.org/10.3892/etm.2020.9495
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Tracheobronchial tuberculosis (TB) leads to airway stenosis, irreversible airway damage and even death. The present study aimed to identify biomarkers for the diagnosis of tracheobronchial stenosis (TBS) secondary to tracheobronchial TB. A cohort was recruited, including patients with TBS after tracheobronchial TB, TBS after tracheal intubation or tracheotomy (TIT) and no stenosis of early‑stage lung cancer,. Proteomic profiling was performed to gain insight into the mechanisms of the pathological processes. Differentially expressed proteins in the serum and bronchial alveolar lavage fluid (BALF) from patients were detected by matrix‑assisted laser desorption ionization time‑of‑flight mass spectrometry (MALDI‑TOF MS). Subsequently, ELISA was performed to validate the changes of protein levels in an additional cohort. MALDI‑TOF MS revealed that 8 peptides in the serum, including myeloid‑associated differentiation marker, keratin type I cytoskeletal 18, fibrinogen α‑chain, angiotensinogen (AGT), apolipoprotein A‑I (APOAI), clusterin and two uncharacterized peptides, and nine peptides in BALF, including argininosuccinate lyase, APOAI, AGT and five uncharacterized peptides, were differentially expressed (molecular‑weight range, 1,000‑10,000 Da) in the TB group compared with the TIT group. The ELISA results indicated that the changes in the protein levels had a similar trend as those identified by proteomic profiling. In conclusion, the present study identified proteins that may serve as potential biomarkers and provide novel insight into the molecular mechanisms underlying TBS after tracheobronchial TB.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Hirshoren N and Eliashar R: Wound-healing modulation in upper airway stenosis-Myths and facts. Head Neck. 31:111–126. 2009.PubMed/NCBI View Article : Google Scholar

2 

Siow WT and Lee P: Tracheobronchial tuberculosis: A clinical review. J Thorac Dis. 9:E71–E77. 2017.PubMed/NCBI View Article : Google Scholar

3 

Nemati A, Safavi E, GhasemiEsfe M, Anaraki MZ, Firoozbakhsh S, Khalilzadeh O and Anvari M: Fistula formation between the right and left main bronchus caused by endobronchial tuberculosis. Am J Med Sci. 343:330–331. 2012.PubMed/NCBI View Article : Google Scholar

4 

Kashyap S, Mohapatra PR and Saini V: Endobronchial tuberculosis. Indian J Chest Dis Allied Sci. 45:247–256. 2003.PubMed/NCBI

5 

Um SW, Yoon YS, Lee SM, Yim JJ, Yoo CG, Chung HS, Kim YW, Han SK, Shim YS and Kim DK: Predictors of persistent airway stenosis in patients with endobronchial tuberculosis. Int J Tuberc Lung Dis. 12:57–62. 2008.PubMed/NCBI

6 

Shahzad T and Irfan M: Endobronchial tuberculosis-a review. J Thorac Dis. 8:3797–3802. 2016.PubMed/NCBI View Article : Google Scholar

7 

Mondoni M, Repossi A, Carlucci P, Centanni S and Sotgiu G: Bronchoscopic techniques in the management of patients with tuberculosis. Int J Infect Dis. 64:27–37. 2017.PubMed/NCBI View Article : Google Scholar

8 

Pathak V, Shepherd RW and Shojaee S: Tracheobronchial tuberculosis. J Thorac Dis. 8:3818–3825. 2016.PubMed/NCBI View Article : Google Scholar

9 

England K, Masini T and Fajardo E: Detecting tuberculosis: Rapid tools but slow progress. Public Health Action. 9:80–83. 2019.PubMed/NCBI View Article : Google Scholar

10 

Fan NJ, Gao CF and Wang XL: Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: A proteomics study. OMICS. 17:215–223. 2013.PubMed/NCBI View Article : Google Scholar

11 

Sobsey CA, Ibrahim S, Richard VR, Gaspar V, Mitsa G, Lacasse V, Zahedi RP, Batist G and Borchers CH: Targeted and untargeted proteomics approaches in biomarker development. Proteomics. 20(e1900029)2020.PubMed/NCBI View Article : Google Scholar

12 

Venkatesh A, Gil C, Fuentes M, LaBaer J and Srivastava S: A Perspective on Proteomics of Infectious Diseases. Proteomics Clin Appl. 12(e1700139)2018.PubMed/NCBI View Article : Google Scholar

13 

Dong W, Qiu C, Gong D, Jiang X, Liu W, Liu W, Zhang L and Zhang W: Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson's disease. Exp Ther Med. 18:2833–2842. 2019.PubMed/NCBI View Article : Google Scholar

14 

Beavis RC and Chait BT: Rapid, sensitive analysis of protein mixtures by mass spectrometry. Proc Natl Acad Sci USA. 87:6873–6877. 1990.PubMed/NCBI View Article : Google Scholar

15 

Stoeckli M, Farmer TB and Caprioli RM: Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument. J Am Soc Mass Spectrom. 10:67–71. 1999.PubMed/NCBI View Article : Google Scholar

16 

Peng Y, Zhang Q, Xu C and Shi W: MALDI-TOF MS for the rapid identification and drug susceptibility testing of filamentous fungi. Exp Ther Med. 18:4865–4873. 2019.PubMed/NCBI View Article : Google Scholar

17 

Cho YT, Su H, Wu WJ, Wu DC, Hou MF, Kuo CH and Shiea J: Biomarker Characterization by MALDI-TOF/MS. Adv Clin Chem. 69:209–254. 2015.PubMed/NCBI View Article : Google Scholar

18 

Davies HA: The ProteinChip System from Ciphergen: A new technique for rapid, micro-scale protein biology. J Mol Med (Berl). 78(B29)2000.PubMed/NCBI

19 

Deng BG, Yao JH, Liu QY, Feng XJ, Liu D, Zhao L, Tu B and Yang F: Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. Asian Pac J Cancer Prev. 14:6069–6075. 2013.PubMed/NCBI View Article : Google Scholar

20 

Malys BJ, Piotrowski ML and Owens KG: Diagnosing and correcting mass accuracy and signal intensity error due to initial ion position variations in a MALDI TOFMS. J Am Soc Mass Spectrom. 29:422–434. 2018.PubMed/NCBI View Article : Google Scholar

21 

Cho Y, Park Y, Sim B, Kim J, Lee H, Cho SN, Kang YA and Lee SG: Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach. Sci Rep. 10(3825)2020.PubMed/NCBI View Article : Google Scholar

22 

Isa F, Collins S, Lee MH, Decome D, Dorvil N, Joseph P, Smith L, Salerno S, Wells MT, Fischer S, et al: Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis. EBioMedicine. 31:157–165. 2018.PubMed/NCBI View Article : Google Scholar

23 

Cui W, Yu L, He H, Chu Y, Gao J, Wan B, Tang L and Zhao S: Cloning of human myeloid-associated differentiation marker (MYADM) gene whose expression was up-regulated in NB4 cells induced by all-trans retinoic acid. Mol Biol Rep. 28:123–138. 2001.PubMed/NCBI View Article : Google Scholar

24 

Aranda JF, Reglero-Real N, Marcos-Ramiro B, Ruiz-Sáenz A, Fernández-Martín L, Bernabé-Rubio M, Kremer L, Ridley AJ, Correas I, Alonso MA, et al: MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. Mol Biol Cell. 24:483–494. 2013.PubMed/NCBI View Article : Google Scholar

25 

Aranda JF, Reglero-Real N, Kremer L, Marcos-Ramiro B, Ruiz-Sáenz A, Calvo M, Enrich C, Correas I, Millán J and Alonso MA: MYADM regulates Rac1 targeting to ordered membranes required for cell spreading and migration. Mol Biol Cell. 22:1252–1262. 2011.PubMed/NCBI View Article : Google Scholar

26 

Sun L, Bai Y, Zhao R, Sun T, Cao R, Wang F, He G, Zhang W, Chen Y, Ye P, et al: Oncological miR-182-3p, a novel smooth muscle cell phenotype modulator, evidences from model rats and patients. Arterioscler Thromb Vasc Biol. 36:1386–1397. 2016.PubMed/NCBI View Article : Google Scholar

27 

Panettieri RA Jr: Airway smooth muscle: An immunomodulatory cell. J Allergy Clin Immunol. 110 (Suppl):S269–S274. 2002.PubMed/NCBI View Article : Google Scholar

28 

Ozier A, Allard B, Bara I, Girodet PO, Trian T, Marthan R and Berger P: The pivotal role of airway smooth muscle in asthma pathophysiology. J Allergy (Cairo). 2011(742710)2011.PubMed/NCBI View Article : Google Scholar

29 

Kim HJ, Park JS, Heo JS, Moon KY and Park CS: Plasma apolipoprotein H levels are different between aspirin induced respiratory diseases and aspirin tolerant asthma. Pulm Pharmacol Ther. 27:184–189. 2014.PubMed/NCBI View Article : Google Scholar

30 

Choi JH, Nguyen MP, Lee D, Oh GT and Lee YM: Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice. Mol Cells. 37:487–496. 2014.PubMed/NCBI View Article : Google Scholar

31 

Zhang X, Ma A, Sun S and Sun Y: Proteomic analysis of plasma in adult active pulmonary tuberculosis patients with diabetes mellitus. Clin Lab. 61:1481–1490. 2015.PubMed/NCBI View Article : Google Scholar

32 

Peix L, Evans IC, Pearce DR, Simpson JK, Maher TM and McAnulty RJ: Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis. Sci Rep. 8(1906)2018.PubMed/NCBI View Article : Google Scholar

33 

Habiel DM, Camelo A, Espindola M, Burwell T, Hanna R, Miranda E, Carruthers A, Bell M, Coelho AL, Liu H, et al: Divergent roles for clusterin in lung injury and repair. Sci Rep. 7(15444)2017.PubMed/NCBI View Article : Google Scholar

34 

Wilson MR and Zoubeidi A: Clusterin as a therapeutic target. Expert Opin Ther Targets. 21:201–213. 2017.PubMed/NCBI View Article : Google Scholar

35 

Nordestgaard LT, Tybjærg-Hansen A, Rasmussen KL, Nordestgaard BG and Frikke-Schmidt R: Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: Cohort studies and meta-analyses of 362,338 individuals. BMC Med. 16(39)2018.PubMed/NCBI View Article : Google Scholar

36 

Foster EM, Dangla-Valls A, Lovestone S, Ribe EM and Buckley NJ: Clusterin in Alzheimer's Disease: Mechanisms, genetics, and lessons from other pathologies. Front Neurosci. 13(164)2019.PubMed/NCBI View Article : Google Scholar

37 

Wang Y, Wang X, Zhao H, Liang B and Du Q: Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression. J Chemother. 24:348–357. 2012.PubMed/NCBI View Article : Google Scholar

38 

Tang Y, Liu F, Zheng C, Sun S and Jiang Y: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. J Exp Clin Cancer Res. 31(73)2012.PubMed/NCBI View Article : Google Scholar

39 

Panico F, Rizzi F, Fabbri LM, Bettuzzi S and Luppi F: Clusterin (CLU) and lung cancer. Adv Cancer Res. 105:63–76. 2009.PubMed/NCBI View Article : Google Scholar

40 

Ma J, Gao W and Gao J: sCLU as prognostic biomarker and therapeutic target in osteosarcoma. Bioengineered. 10:229–239. 2019.PubMed/NCBI View Article : Google Scholar

41 

Bertacchini J, Mediani L, Beretti F, Guida M, Ghalali A, Brugnoli F, Bertagnolo V, Petricoin E, Poti F, Arioli J, et al: Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit. J Cell Physiol. 234:11188–11199. 2019.PubMed/NCBI View Article : Google Scholar

42 

Charlton-Menys V and Durrington P: Apolipoproteins AI and B as therapeutic targets. J Intern Med. 259:462–472. 2006.PubMed/NCBI View Article : Google Scholar

43 

Dong Z, Guo Q, Sun L, Li F, Zhao A, Liu J, Qu P, Zhu Q, Xiao C, Niu F, et al: Serum lipoprotein and RBC rigidity index to predict cerebral infarction in patients with carotid artery stenosis. J Clin Lab Anal. 32(e22356)2018.PubMed/NCBI View Article : Google Scholar

44 

Mateos J, Estévez O, González-Fernández Á, Anibarro L, Pallarés Á, Reljic R, Mussá T, Gomes-Maueia C, Nguilichane A, Gallardo JM, et al: Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection. Sci Rep. 10(3844)2020.PubMed/NCBI View Article : Google Scholar

45 

Albanna AS, Bachmann K, White D, Valiquette C and Menzies D: Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection. Eur Respir J. 42:547–550. 2013.PubMed/NCBI View Article : Google Scholar

46 

Wang C, Wei LL, Shi LY, Pan ZF, Yu XM, Li TY, Liu CM, Ping ZP, Jiang TT, Chen ZL, et al: Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis. Sci Rep. 5(15615)2015.PubMed/NCBI View Article : Google Scholar

47 

Wang W, Xu H, Shi Y, Nandedkar S, Zhang H, Gao H, Feroah T, Weihrauch D, Schulte ML, Jones DW, et al: Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung. J Lipid Res. 51:2560–2570. 2010.PubMed/NCBI View Article : Google Scholar

48 

Yao X, Dai C, Fredriksson K, Dagur PK, McCoy JP, Qu X, Yu ZX, Keeran KJ, Zywicke GJ, Amar MJ, et al: 5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma. J Immunol. 186:576–583. 2011.PubMed/NCBI View Article : Google Scholar

49 

Kwan R, Looi KS and Omary MB: Absence of keratins 8 and 18 in rodent epithelial cell lines associates with keratin gene mutation and DNA methylation: Cell line selective effects on cell invasion. Exp Cell Res. 335:12–22. 2015.PubMed/NCBI View Article : Google Scholar

50 

Zhang H, Chen X, Wang J, Guang W, Han W, Zhang H, Tan X and Gu Y: EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression. Sci Rep. 4(5416)2014.PubMed/NCBI View Article : Google Scholar

51 

Wang X, Lao Y, Xu N, Xi Z, Wu M, Wang H, Li X, Tan H, Sun M and Xu H: Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins. SciRep. 5(10293)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Peng B, Qiu X, Dong Z, Zhang J, Pei Y and Wang T: Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis. Exp Ther Med 21: 63, 2021.
APA
Peng, B., Qiu, X., Dong, Z., Zhang, J., Pei, Y., & Wang, T. (2021). Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis. Experimental and Therapeutic Medicine, 21, 63. https://doi.org/10.3892/etm.2020.9495
MLA
Peng, B., Qiu, X., Dong, Z., Zhang, J., Pei, Y., Wang, T."Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 21.1 (2021): 63.
Chicago
Peng, B., Qiu, X., Dong, Z., Zhang, J., Pei, Y., Wang, T."Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 21, no. 1 (2021): 63. https://doi.org/10.3892/etm.2020.9495
Copy and paste a formatted citation
x
Spandidos Publications style
Peng B, Qiu X, Dong Z, Zhang J, Pei Y and Wang T: Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis. Exp Ther Med 21: 63, 2021.
APA
Peng, B., Qiu, X., Dong, Z., Zhang, J., Pei, Y., & Wang, T. (2021). Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis. Experimental and Therapeutic Medicine, 21, 63. https://doi.org/10.3892/etm.2020.9495
MLA
Peng, B., Qiu, X., Dong, Z., Zhang, J., Pei, Y., Wang, T."Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 21.1 (2021): 63.
Chicago
Peng, B., Qiu, X., Dong, Z., Zhang, J., Pei, Y., Wang, T."Proteomic profiling of biomarkers by MALDI‑TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 21, no. 1 (2021): 63. https://doi.org/10.3892/etm.2020.9495
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team